Literature DB >> 9280067

Comparison of 6-s-cis- and 6-s-trans-locked analogs of 1alpha,25-dihydroxyvitamin D3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s-trans-locked analogs are preferred for genomic biological responses.

A W Norman1, W H Okamura, M W Hammond, J E Bishop, M C Dormanen, R Bouillon, H van Baelen, A L Ridall, E Daane, R Khoury, M C Farach-Carson.   

Abstract

The hormone 1alpha,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3] generates biological responses via both genomic and rapid, nongenomic mechanisms. The genomic responses utilize signal transduction pathways linked to a nuclear receptor (VDRnuc) for 1alpha,25(OH)2D3, while the rapid responses are believed to utilize other signal transduction pathways that may be linked to a putative membrane receptor for 1alpha,25(OH)2D3. The natural seco steroid is capable of facile rotation about its 6,7 single carbon bond, which permits generation of a continuum of potential ligand shapes extending from the 6-s-cis (steroid like) to the 6-s-trans (extended). To identify the shape of conformer(s) that can serve as agonists for the genomic and rapid biological responses, we measured multiple known agonist activities of two families of chemically synthesized analogs that were either locked in the 6-s-cis (6C) or 6-s-trans (6T) conformation. We found that 6T locked analogs were inactive or significantly less active than 1alpha,25(OH)2D3 in both rapid responses (transcaltachia in perfused chick intestine, 45Ca2+ influx in ROS 17/2.8 cells) and genomic (osteocalcin induction in MG-63 cells, differentiation of HL-60 cells, growth arrest of MCF-7 cells, promoter transfection in COS-7 cells) assays. In genomic assays, 6C locked analogs bound poorly to the VDRnuc and were significantly less effective than 1alpha,25(OH)2D3 in the same series of assays designed to measure genomic responses. In contrast, the 6C locked analogs were potent agonists of both rapid response pathways and had activities equivalent to the conformationally flexibile 1alpha,25(OH)2D3; this represents the first demonstration that 6-s-cis locked analogs can function as agonists for vitamin D responses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9280067     DOI: 10.1210/mend.11.10.9993

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  18 in total

Review 1.  Structure function studies: identification of vitamin D analogs for the ligand-binding domains of important proteins in the vitamin D-endocrine system.

Authors:  A W Norman; F R Silva
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  Nongenomic vitamin D3 analogs activating ERK2 in HL-60 cells show that retinoic acid-induced differentiation and cell cycle arrest require early concurrent MAPK and RAR and RXR activation.

Authors:  A Yen; A W Norman; S Varvayanis
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-02       Impact factor: 2.416

3.  Vitamin D deficiency promotes skeletal muscle hypersensitivity and sensory hyperinnervation.

Authors:  Sarah E Tague; Gwenaëlle L Clarke; Michelle K Winter; Kenneth E McCarson; Douglas E Wright; Peter G Smith
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

4.  Vitamin D receptor (VDR) regulation of voltage-gated chloride channels by ligands preferring a VDR-alternative pocket (VDR-AP).

Authors:  Danusa Menegaz; Mathew T Mizwicki; Antonio Barrientos-Duran; Ning Chen; Helen L Henry; Anthony W Norman
Journal:  Mol Endocrinol       Date:  2011-06-09

Review 5.  Vitamin D metabolism, mechanism of action, and clinical applications.

Authors:  Daniel D Bikle
Journal:  Chem Biol       Date:  2014-02-13

6.  Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling.

Authors:  Mathew T Mizwicki; Don Keidel; Craig M Bula; June E Bishop; Laura P Zanello; Jean-Marie Wurtz; Dino Moras; Anthony W Norman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

Review 7.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

Review 8.  Pleiotropic Activities of Vitamin D Receptors - Adequate Activation for Multiple Health Outcomes.

Authors:  Jackson W Ryan; Paul H Anderson; Howard A Morris
Journal:  Clin Biochem Rev       Date:  2015-05

9.  Human sperm anatomy: ultrastructural localization of 1alpha,25-dihydroxyvitamin D receptor and its possible role in the human male gamete.

Authors:  Saveria Aquila; Carmela Guido; Ida Perrotta; Sandro Tripepi; Alfonso Nastro; Sebastiano Andò
Journal:  J Anat       Date:  2008-11       Impact factor: 2.610

10.  Human male gamete endocrinology: 1alpha, 25-dihydroxyvitamin D3 (1,25(OH)2D3) regulates different aspects of human sperm biology and metabolism.

Authors:  Saveria Aquila; Carmela Guido; Emilia Middea; Ida Perrotta; Rosalinda Bruno; Michele Pellegrino; Sebastiano Andò
Journal:  Reprod Biol Endocrinol       Date:  2009-11-30       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.